HealthEquity, Inc.
Market Cap
$6.92B
P/E Ratio
36.68
EPS
$2.18
Dividend Yield
0.00%
52-Week Range
$72.76 — $116.65
Volume
572.54K
Avg Volume
981.26K
Beta
0.32
P/E (TTM)
36.68
Forward P/E
20.22
PEG Ratio
1.14
P/S (TTM)
5.36
P/B (TTM)
3.23
P/FCF
59.03
EV/EBITDA
73.55x
EV/Sales
—
ROE (TTM)
0.09%
ROA (TTM)
0.06%
ROIC
0.02%
Gross Margin
0.61%
Operating Margin
0.25%
Net Margin
0.16%
Debt/Equity
0.48
Current Ratio
4.13
EPS Growth (YoY)
+8.19%
Revenue Growth (YoY)
+0.09%
EPS Growth (3Y)
+1.41%
EPS Growth (5Y)
-0.40%
Sales Growth (3Y)
+0.17%
Sales Growth (5Y)
+0.18%
EPS Est (This Year)
$3.96
EPS Est (Next Year)
$4.54
Dividend Yield
—
Annual Dividend
—
Payout Ratio
0.00%
Frequency
—
Ex-Dividend Date
—
Cash/Share
$3.60
Sell
1 = Strong Buy, 5 = Strong Sell
Price Target Range
Consensus Target: $107.67(34.6% upside)
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
86.48M
Float
83.81M
Free Float %
96.92%
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Country
US
Exchange
NASDAQ
IPO Date
2014-07-31
Employees
3105
CEO
Scott R. Cutler
Index Membership
—
Website
https://www.healthequity.com
HealthEquity, Inc. (HQY) is a healthcare company in the medical - healthcare information services industry listed on the NASDAQ. With a market capitalization of $6.92B, a P/E ratio of 36.68, HQY is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare HQY against other stocks using dozens of fundamental and technical filters.
HealthEquity, Inc. (HQY) has a trailing twelve-month (TTM) P/E ratio of 36.68. This is above the market average, which may reflect high growth expectations or premium valuation. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, HealthEquity, Inc. (HQY) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
HealthEquity, Inc. (HQY) has a market capitalization of $6.92 billion, classifying it as a mid-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.
Wall Street analysts have a consensus "Sell" rating on HealthEquity, Inc. (HQY) with an average score of 4.00 on a 1-5 scale (1 = Strong Buy, 5 = Strong Sell). The consensus price target of $107.67 implies 34.6% upside from the current price.